Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Atherosclerosis

• Publication date

  2010-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.atherosclerosis.2009.08.033PMID 19740466
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiogenesis achieved by granulocyte colony-stimulating factor in combination with bypass surgery in 2 cases of critical limb ischemia.

  2008cited by this paper
• Beneficial effects of autologous bone marrow cell infusion and antioxidants/L-arginine in patients with chronic critical limb ischemia

  2008cited by this paper
• Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.

  2008cited by this paper
• Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia.

  2008cited by this paper
• Endothelial progenitor cells in the natural history of atherosclerosis.

  2007cited by this paper
• Quality of life improvement and long-term effects of peripheral blood mononuclear cell transplantation for severe arteriosclerosis obliterans in diabetic patients on dialysis.

  2007cited by this paper
• Significance of Endothelial Progenitor Cells in Subjects with Diabetes Mellitus

  2007cited by this paper
• Wound therapy with autologous bone marrow stem cells in diabetic patients with ischaemia‐induced tissue ulcers affecting the lower limbs

  2007cited by this paper
• Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans

  2007cited by this paper
• Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials.

  2007cited by this paper
• Granulocyte colony-stimulating factor: a noninvasive regeneration therapy for treating atherosclerotic peripheral artery disease.

  2006cited by this paper
• Marked Decrease of Plasma VEGF After Implantation of Autologous Bone Marrow Mononuclear Cells in a Patient with Critical Limb Ischemia

  2006cited by this paper
• Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy

  2006cited by this paper
• Effects of Granulocyte Colony Simulating Factor on Functional Activities of Endothelial Progenitor Cells in Patients With Chronic Ischemic Heart Disease

  2006cited by this paper
• Unblinded Pilot Study of Autologous Transplantation of Bone Marrow Mononuclear Cells in Patients With Thromboangiitis Obliterans

  2006cited by this paper
• Autoperipheral blood mononuclear cell transplantation improved giant ulcers due to chronic arteriosclerosis obliterans

  2006cited by this paper
• Critical Limb Ischemia and Stem Cell Research: Anchoring Hope With Informed Adverse Event Reporting

  2006cited by this paper
• Medical treatment of peripheral arterial disease.

  2006cited by this paper
• Angiogenesis Facilitated by Autologous Whole Bone Marrow Stem Cell Transplantation for Buerger's Disease

  2006cited by this paper
• Thromboangiitis obliterans (Buerger's disease)

  2006cited by this paper
• Successful Stem Cell Therapy Using Umbilical Cord Blood‐Derived Multipotent Stem Cells for Buerger's Disease and Ischemic Limb Disease Animal Model

  2006cited by this paper
• Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk.

  2006cited by this paper
• Autologous bone marrow mononuclear cell implantation induces angiogenesis and bone regeneration in a patient with compartment syndrome.

  2006cited by this paper
• Granulocyte Colony-Stimulating Factor A Noninvasive Regeneration Therapy for Treating Atherosclerotic Peripheral Artery Disease

  2006cited by this paper
• Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy?

  2005cited by this paper
• Prevention of Limb Amputation in Patients with Limbs Ulcers by Autologous Peripheral Blood Mononuclear Cell Implantation

  2005cited by this paper
• START Trial: A Pilot Study on STimulation of ARTeriogenesis Using Subcutaneous Application of Granulocyte-Macrophage Colony-Stimulating Factor as a New Treatment for Peripheral Vascular Disease

  2005cited by this paper
• Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus.

  2005cited by this paper
• Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes.

  2005cited by this paper
• Impaired progenitor cell activity in age-related endothelial dysfunction.

  2005cited by this paper
• A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware.

  2004cited by this paper
• Peripheral arterial disease detection, awareness, and treatment in primary care.

  2001cited by this paper
• Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care

  2001cited by this paper
• Thromboangiitis obliterans (Buerger's disease).

  2000cited by this paper
• Meta-analysis of observational studies in epidemiology - A proposal for reporting

  2000cited by this paper
• Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

  2000cited by this paper
• Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: The QUOROM Statement

  1999cited by this paper
• Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses.

  1999cited by this paper
• Isolation of Putative Progenitor Endothelial Cells for Angiogenesis

  1997cited by this paper

• Angiogenic therapy in peripheral arterial disease with granulocyte colony-stimulating factor (G-CSF)

  2026cites this paper
• [Prospects for stromal-vascular fraction in the treatment of lower limb ischemia].

  2025cites this paper
• Advancements in utilizing CD34+ stem cells for repairing diabetic vascular damage.

  2025cites this paper
• Особенности применения клеточной терапии у пациентов с критической ишемией нижних конечностей

  2025cites this paper
• Our Experience with Stem Cell Applications in Patients with Advanced Peripheral Arterial Disease

  2025cites this paper
• NRP1-expressing monocyte/macrophages promote arteriogenesis in the ischemic limb

  2024cites this paper
• Salvataje de amputación mediante la aplicación de células madre autólogas de médula ósea en isquemia crítica de miembro inferior: reporte de caso

  2024cites this paper
• The Immune-Centric Revolution Translated into Clinical Application: Peripheral Blood Mononuclear Cell (PBMNC) Therapy in Diabetic Patients with No-Option Critical Limb-Threatening Ischemia (NO-CLTI)—Rationale and Meta-Analysis of Observational Studies

  2024cites this paper
• Mesenchymal Stem/Stromal Cells for Therapeutic Angiogenesis

  2023cites this paper
• Knowledge Mapping of Global Status and Trends for Thromboangiitis Obliterans: A Bibliometrics and Visual Analysis

  2023cites this paper
• Top 100 cited articles in the thromboangiitis obliterans: a bibliometric analysis and visualized study

  2023cites this paper
• HTATIP2 regulates arteriogenic activity in monocytes from patients with limb ischemia

  2023cites this paper
• Near-infrared light-driven multifunctional metal ion (Cu2+)-loaded polydopamine nanomotors for therapeutic angiogenesis in critical limb ischemia

  2023cites this paper
• Cell Therapy of Vascular and Neuropathic Complications of Diabetes: Can We Avoid Limb Amputation?

  2023cites this paper
• Cell Therapy of Severe Ischemia in People with Diabetic Foot Ulcers—Do We Have Enough Evidence?

  2023cites this paper
• Therapeutic use of Stem Cells, Blood and Bone Marrow Products

  2023cites this paper
• Emerging roles of mesenchymal stem cell therapy in patients with critical limb ischemia

  2022cites this paper
• Therapeutic Angiogenesis Using Autologous CD34-Positive Cells for Vascular Diseases

  2022cites this paper
• Comparison of the impact of autologous cell therapy and conservative standard treatment on tissue oxygen supply and course of the diabetic foot in patients with chronic limb-threatening ischemia: A randomized controlled trial

  2022cites this paper
• Autologous Cellular Therapy

  2022cites this paper
• Autologous Cellular Therapy

  2022cites this paper
• Effect of autological red bone marrow aspirates on the microcirculation in the lower extremities of patients with diabetic angiopathy

  2022cites this paper
• Implantation of Hypoxia-Induced Mesenchymal Stem Cell Advances Therapeutic Angiogenesis

  2022cites this paper
• Opportunities and challenges in stem cell therapy in cardiovascular diseases: Position standing in 2022

  2022cites this paper
• Mesenchymal stem cells for critical limb ischemia: their function, mechanism, and therapeutic potential

  2022cites this paper
• Options for imaging cellular therapeutics in vivo: a multi-stakeholder perspective.

  2021cites this paper
• CD146+Mesenchymal stem cells treatment improves vascularization, muscle contraction and VEGF expression, and reduces apoptosis in rat ischemic hind limb.

  2021cites this paper
• The Management of Ischemic Limb in Thromboangiitis Obliterans (Buerger’s Disease)

  2021cites this paper
• To be or not to be: endothelial cell plasticity in development, repair, and disease

  2021cites this paper
• Current Status of Angiogenic Cell Therapy and Related Strategies Applied in Critical Limb Ischemia

  2021cites this paper
• Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy

  2021cites this paper
• (Accepted/In press). Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy. Current diabetes reports.

  2021cites this paper
• To be or not to be: endothelial cell plasticity in development, repair, and disease

  2021cites this paper
• ROS-responsive nanoparticle-mediated delivery of CYP2J2 gene for therapeutic angiogenesis in severe hindlimb ischemia

  2021cites this paper
• A Meta-Analysis of Randomized Controlled Trials on Therapeutic Efficacy and Safety of Autologous Cell Therapy for Atherosclerosis Obliterans.

  2021cites this paper
• Influence of autologous bone marrow fraction and simvastatin on microcirculation of leg muscles in experimental critical ischemia of the lower limbs

  2021cites this paper
• Low-intensity pulsed ultrasound decreases major amputation in patients with critical limb ischemia: 5-year follow-up study

  2021cites this paper
• Autologous Cellular Therapy

  2021cites this paper
• Effect of intentional restriction of venous return on tissue oxygenation in a porcine model of acute limb ischemia

  2020cites this paper
• Changing the Course of Peripheral Arterial Disease Using Adult Stem Progenitor Cells

  2020cites this paper
• Autologous Cellular Therapy for Certain Indications – Commercial Medical Policy

  2020cites this paper
• Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Safety and Therapeutic Efficacy of Angiogenesis Induced by Intraarterial Autologous Bone Marrow-Derived Stem Cells in Patients with Severe Peripheral Arterial Disease.

  2020cites this paper
• REX-001, a BM-MNC Enriched Solution, Induces Revascularization of Ischemic Tissues in a Murine Model of Chronic Limb-Threatening Ischemia

  2020cites this paper
• Relationship between cell number and clinical outcomes of autologous bone-marrow mononuclear cell implantation in critical limb ischemia

  2020cites this paper
• Characterization of Proangiogenic Monocytes from Blood in Patients with Chronic Ischemic Diabetic Foot Ulcers and Controls

  2020cites this paper
• The Effect of Autologous Dedifferentiated Fat Cell Transplantation in a Pig Model of Hindlimb Ischemia

  2020cites this paper
• Vascular Pain

  2020cites this paper
• Blood Flow Restriction Exercise Stimulates Mobilization of Hematopoietic Stem/Progenitor Cells and Increases the Circulating ACE2 Levels in Healthy adults.

  2020cites this paper
• Current Status of Cell-Based Therapy in Patients with Critical Limb Ischemia

  2020cites this paper
• Role of Modern Technologies in Tissue Engineering

  2020cites this paper
• FEASIBILITY

  2020cites this paper
• Review of the Long-term Effects of Autologous Bone-Marrow Mononuclear Cell Implantation on Clinical Outcomes in Patients with Critical Limb Ischemia

  2019cites this paper
• Efficacy of Different Doses of Human Autologous Adult Bone Marrow Stem Cell Transplantation on Angiogenesis in an Immune Deficient Rat Model with Hind Limb Ischemia

  2019cites this paper
• Autologous Skeletal Myoblast/Mononuclear Bone Marrow Cell Transplantation

  2019cites this paper
• Impact of severe diabetic kidney disease on the clinical outcome of autologous cell therapy in people with diabetes and critical limb ischaemia

  2019cites this paper
• Peripheral artery disease: the new frontiers of imaging techniques to evaluate the evolution of regenerative medicine

  2019cites this paper
• of Regenerative Medicine CD133 Clinical Trials: Safety and Efficacy

  2019cites this paper
• Encapsulation of macrophages enhances their retention and angiogenic potential

  2019cites this paper
• Activation of stem cell up-regulation/mobilization: a cardiovascular risk in both mice and humans with implications for liver disease, psoriasis and SLE

  2019cites this paper
• Therapeutic angiogenesis: From conventional approaches to recent nanotechnology-based interventions.

  2019cites this paper
• Therapeutic efficacy of CD34+ cell-involved mononuclear cell therapy for no-option critical limb ischemia: A meta-analysis of randomized controlled clinical trials

  2018cites this paper
• Title Concise Review: Endothelial Progenitor Cells in Regenerative Medicine: Applications and Challenges

  2018cites this paper
• Autologous Cell Therapy for Cardiac and Peripheral Arterial Disease

  2018cites this paper
• Extensive skeletal muscle cell mitochondriopathy distinguishes critical limb ischemia patients from claudicants.

  2018cites this paper
• Efficacy and long-term longitudinal follow-up of bone marrow mesenchymal cell transplantation therapy in a diabetic patient with recurrent lower limb bullosis diabeticorum

  2018cites this paper
• Endothelial and cardiac progenitor cells for cardiovascular repair: A controversial paradigm in cell therapy

  2018cites this paper
• Endothelial Progenitor Cells Biology in Diabetes Mellitus and Peripheral Arterial Disease and their Therapeutic Potential

  2018cites this paper
• Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients.

  2018cites this paper
• Reversible secretome and signaling defects in diabetic mesenchymal stem cells from peripheral arterial disease patients

  2018cites this paper
• Long-Term Clinical Outcomes Survey of Bone Marrow-Derived Cell Therapy in Critical Limb Ischemia in Japan.

  2018cites this paper
• Purified CD34+ cells versus peripheral blood mononuclear cells in the treatment of angiitis-induced no-option critical limb ischaemia: 12-Month results of a prospective randomised single-blinded non-inferiority trial

  2018cites this paper
• Microarray analysis for delineating the gene expression in biopsies of gastrocnemius muscle of patients with chronic critical limb ischaemia compared with non-ischaemic controls.

  2018cites this paper
• Regulation of angiogenesis by microRNAs in cardiovascular diseases

  2018cites this paper
• The use of miR-92a inhibitor to enhance endothelial progenitor cell-mediated regeneration of injured arteries

  2018cites this paper
• Improved recovery from limb ischaemia by delivery of an affinity-isolated heparan sulphate

  2018cites this paper
• Perfusion scintigraphy in the assessment of autologous cell therapy in diabetic patients with critical limb ischemia.

  2018cites this paper
• Autologous platelet-rich plasma for treatment of ischemic ulcers in buerger's disease: A pilot study with short-term results

  2018cites this paper
• The CIRSE Research Infrastructure: our 5-year experience

  2018cites this paper
• Endothelial colony‐forming cells and pro‐angiogenic cells: clarifying definitions and their potential role in mitigating acute kidney injury

  2018cites this paper
• Critical limb ischemia: current challenges and future prospects

  2018cites this paper
• Difference in Serum Endostatin Levels in Diabetic Patients with Critical Limb Ischemia Treated by Autologous Cell Therapy or Percutaneous Transluminal Angioplasty

  2018cites this paper
• Stem cell therapy for treatment of thromboangiitis obliterans (Buerger's disease).

  2018cites this paper
• Endothelial progenitor cell miR-126 promotes homing of endothelial progenitor cells within arterial thrombus in patients with cerebral infarction and its molecular mechanism.

  2018cites this paper
• Human primary CD34+ cells transplantation for critical limb ischemia

  2018cites this paper
• Die Stimulation von Vorläuferzellen des Gefäßendothels zeigt keinen zum Laufbandtraining zusätzlichen Effekt auf die 6-Minuten Gehstrecke

  2018cites this paper
• A Molecular and Clinical Review of Stem Cell Therapy in Critical Limb Ischemia

  2017cites this paper
• Stem-cell Therapy for Peripheral Arterial Disease Policy # 00298

  2017cites this paper
• Stem cell‐based peripheral vascular regeneration

  2017cites this paper
• Autologous Cell Therapy for Peripheral Arterial Disease: Systematic Review and Meta-Analysis of Randomized, Nonrandomized, and Noncontrolled Studies.

  2017cites this paper
• Modulating putative endothelial progenitor cells for the treatment of endothelial dysfunction and cardiovascular complications in diabetes.

  2017cites this paper
• Clinical features and predictors of patients with critical limb ischemia who responded to autologous mononuclear cell transplantation for therapeutic angiogenesis

  2017cites this paper
• Autologous Bone Marrow Mononuclear Cell Implantation and Its Impact on the Outcome of Patients With Critical Limb Ischemia　- Results of a Randomized, Double-Blind, Placebo-Controlled Trial.

  2017cites this paper
• Wounds Difficult to Heal: An Effective Treatment Strategy.

  2017cites this paper
• Concise Review: Perspectives and Clinical Implications of Bone Marrow and Circulating Stem Cell Defects in Diabetes

  2017cites this paper
• Safety and Effectiveness of Bone Marrow Cell Concentrate in the Treatment of Chronic Critical Limb Ischemia Utilizing a Rapid Point-of-Care System

  2017cites this paper
• Rationale and design of the MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe Peripheral Arterial Disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia

  2017cites this paper
• Cell Therapy for Peripheral Arterial Disease

  2017cites this paper
• Uso de células pluripotenciales en el tratamiento de la isquemia crítica

  2017cites this paper
• iPSCs-based generation of vascular cells: reprogramming approaches and applications

  2017cites this paper
• MicroRNAs in Diabetes and Its Vascular Complications

  2017cites this paper